SIMCERE PHARMACEUTICAL GROUP Pre-Tax Income
SIMCERE PHARMACEUTICAL GROUP reported Pre-Tax Income of -CNY 19.98 million for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2013-04-26
CNY
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|
| 2012-12-31 | -19.98M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 116.46M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 195.29M CNY 20-F · filed 2013-04-26 |
| 2009-12-31 | 45.77M CNY 20-F · filed 2012-04-25 |
USD
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|
| 2012-12-31 | -$3.21M 20-F · filed 2013-04-26 |